{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:16:31Z","timestamp":1780326991784,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"phenox"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol Exp"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s41747-018-0084-z","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T09:53:01Z","timestamp":1548237181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["In vivo canine study of three different coatings applied to p64 flow-diverter stents: initial biocompatibility study"],"prefix":"10.1186","volume":"3","author":[{"given":"Rosa","family":"Mart\u00ednez Moreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5514-5237","authenticated-orcid":false,"given":"Pervinder","family":"Bhogal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Lenz-Habijan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrin","family":"Bannewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Lylyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Hannes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Monstadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Henkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,22]]},"reference":[{"key":"84_CR1","doi-asserted-by":"crossref","unstructured":"Mauri G, Sconfienza LM, Casilli F, Massaro S, Inglese L (2013) Cardiatis multilayer stent for endovascular treatment of peripheral and visceral aneurysms: where do we stand? J Endovasc Ther 20:575\u2013577","DOI":"10.1583\/13-4294C.1"},{"key":"84_CR2","doi-asserted-by":"crossref","unstructured":"Kadirvel R, Ding YH, Dai D, Rezek I, Lewis DA, Kallmes DF (2014) Cellular mechanisms of aneurysm occlusion after treatment with a flow diverter. Radiology 270:394\u2013399","DOI":"10.1148\/radiol.13130796"},{"key":"84_CR3","first-page":"443","volume":"50","author":"I Sheiban","year":"2002","unstructured":"Sheiban I, Carrieri L, Catuzzo B et al (2002) Drug-eluting stent: the emerging technique for the prevention of restenosis. Minerva Cardioangiol 50:443\u2013453","journal-title":"Minerva Cardioangiol"},{"key":"84_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1161\/01.CIR.103.2.192","volume":"103","author":"JE Sousa","year":"2001","unstructured":"Sousa JE, Costa MA, Abizaid A et al (2001) Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 103:192\u2013195","journal-title":"Circulation"},{"key":"84_CR5","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1161\/hc4201.098056","volume":"104","author":"JE Sousa","year":"2001","unstructured":"Sousa JE, Costa MA, Abizaid AC et al (2001) Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 104:2007\u20132011","journal-title":"Circulation"},{"key":"84_CR6","doi-asserted-by":"crossref","unstructured":"Sousa JE, Costa MA, Sousa AG et al (2003) Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 107:381\u2013383","DOI":"10.1161\/01.CIR.0000051720.59095.6D"},{"key":"84_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/01.CIR.0000047063.22006.41","volume":"107","author":"JE Sousa","year":"2003","unstructured":"Sousa JE, Costa MA, Abizaid A et al (2003) Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 107:24\u201327","journal-title":"Circulation"},{"key":"84_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0033-0620(96)80022-3","volume":"39","author":"Y Ozaki","year":"1996","unstructured":"Ozaki Y, Violaris AG, Serruys PW (1996) New stent technologies. Prog Cardiovasc Dis 39:129\u2013140","journal-title":"Prog Cardiovasc Dis"},{"key":"84_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1023\/A:1005703106724","volume":"13","author":"AG Violaris","year":"1997","unstructured":"Violaris AG, Ozaki Y, Serruys PW (1997) Endovascular stents: a \u2018break through technology\u2019, future challenges. Int J Card Imaging 13:3\u201313","journal-title":"Int J Card Imaging"},{"key":"84_CR10","first-page":"127","volume":"3","author":"DM Whelan","year":"1998","unstructured":"Whelan DM, van Beusekom HM, van der Giessen WJ (1998) Mechanisms of drug loading and release kinetics. Semin Interv Cardiol 3:127\u2013131","journal-title":"Semin Interv Cardiol"},{"key":"84_CR11","doi-asserted-by":"crossref","unstructured":"Lincoff AM, Furst JG, Ellis SG, Tuch RJ, Topol EJ (1997) Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J Am Coll Cardiol 29:808\u2013816","DOI":"10.1016\/S0735-1097(96)00584-0"},{"key":"84_CR12","first-page":"191","volume":"3","author":"SH Park","year":"1998","unstructured":"Park SH, Lincoff AM (1998) Anti-inflammatory stent coatings: dexamethasone and related compounds. Semin Interv Cardiol 3:191\u2013195","journal-title":"Semin Interv Cardiol"},{"key":"84_CR13","unstructured":"Gershlick AH (1998) Local delivery of glycoprotein IIb\/IIIa receptor inhibitors using drug eluting stents. Semin Interv Cardiol 3:185\u2013190"},{"key":"84_CR14","doi-asserted-by":"crossref","unstructured":"Aggarwal RK, Ireland DC, Azrin MA, Ezekowitz MD, de Bono DP, Gershlick AH (1996) Antithrombotic potential of polymer-coated stents eluting platelet glycoprotein IIb\/IIIa receptor antibody. Circulation 94:3311\u20133317","DOI":"10.1161\/01.CIR.94.12.3311"},{"key":"84_CR15","doi-asserted-by":"crossref","unstructured":"Chen C, Lumsden AB, Ofenloch JC et al (1997) Phosphorylcholine coating of ePTFE grafts reduces neointimal hyperplasia in canine model. Ann Vasc Surg 11:74\u201379","DOI":"10.1007\/s100169900013"},{"key":"84_CR16","doi-asserted-by":"crossref","unstructured":"Chen C, Ofenloch JC, Yianni YP, Hanson SR, Lumsden AB (1998) Phosphorylcholine coating of ePTFE reduces platelet deposition and neointimal hyperplasia in arteriovenous grafts. J Surg Res 77:119\u2013125","DOI":"10.1006\/jsre.1998.5399"},{"key":"84_CR17","doi-asserted-by":"publisher","first-page":"M853","DOI":"10.1097\/00002480-199407000-00118","volume":"40","author":"EJ Campbell","year":"1994","unstructured":"Campbell EJ, O\u2019Byrne V, Stratford PW et al (1994) Biocompatible surfaces using methacryloylphosphorylcholine laurylmethacrylate copolymer. ASAIO J 40:M853\u2013M857","journal-title":"ASAIO J"},{"key":"84_CR18","doi-asserted-by":"publisher","unstructured":"Hanel RA, Aguilar-Salinas P, Brasiliense LB, Sauvageau E (2017) First US experience with pipeline flex with shield technology using aspirin as antiplatelet monotherapy. BMJ Case Rep. J Neurointerv Surg. BMJ Case Rep 2017;2017:bcr-2017-219406. \n                    https:\/\/doi.org\/10.1136\/bcr-2017-219406\n                    \n                  . Accessed 8 Jan 2018","DOI":"10.1136\/bcr-2017-219406"},{"key":"84_CR19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/1591019917753824","volume":"24","author":"K Orlov","year":"2018","unstructured":"Orlov K, Kislitsin D, Strelnikov N et al (2018) Experience using pipeline embolization device with Shield Technology in a patient lacking a full postoperative dual antiplatelet therapy regimen. Interv Neuroradiol 24:270\u2013273","journal-title":"Interv Neuroradiol"},{"key":"84_CR20","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Gald\u00e1mez M, Lamin SM, Lagios KG et al (2017) Periprocedural outcomes and early safety with the use of the Pipeline Flex Embolization Device with Shield Technology for unruptured intracranial aneurysms: preliminary results from a prospective clinical study. J Neurointerv Surg 9:772\u2013776","DOI":"10.1136\/neurintsurg-2016-012896"},{"key":"84_CR21","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s00270-018-2036-7","volume":"41","author":"T Lenz-Habijan","year":"2018","unstructured":"Lenz-Habijan T, Bhogal P, Peters M et al (2018) Hydrophilic stent coating inhibits platelet adhesion on stent surfaces: initial results in vitro. Cardiovasc Intervent Radiol 41:1779\u20131785","journal-title":"Cardiovasc Intervent Radiol"},{"key":"84_CR22","doi-asserted-by":"crossref","unstructured":"Darsaut TE, Bing F, Salazkin I, Gevry G, Raymond J (2012) Flow diverters failing to occlude experimental bifurcation or curved sidewall aneurysms: an in vivo study in canines. J Neurosurg 117:37\u201344","DOI":"10.3171\/2012.4.JNS111916"},{"key":"84_CR23","doi-asserted-by":"crossref","unstructured":"Darsaut TE, Bing F, Makoyeva A, Gevry G, Salazkin I, Raymond J (2014) Flow diversion of giant curved sidewall and bifurcation experimental aneurysms with very-low-porosity devices. World Neurosurg 82:1120\u20131126","DOI":"10.1016\/j.wneu.2013.09.036"},{"key":"84_CR24","doi-asserted-by":"crossref","unstructured":"Darsaut TE, Bing F, Salazkin I, Gevry G, Raymond J (2012) Flow diverters can occlude aneurysms and preserve arterial branches: a new experimental model. AJNR Am J Neuroradiol 33:2004\u20132009","DOI":"10.3174\/ajnr.A3075"},{"key":"84_CR25","doi-asserted-by":"crossref","unstructured":"Fahed R, Gentric JC, Salazkin I, Gevry G, Raymond J, Darsaut TE (2017) Flow diversion of bifurcation aneurysms is more effective when the jailed branch is occluded: an experimental study in a novel canine model. J Neurointerv Surg 9:311\u2013315","DOI":"10.1136\/neurintsurg-2015-012240"},{"key":"84_CR26","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3174\/ajnr.A4336","volume":"36","author":"I Szikora","year":"2015","unstructured":"Szikora I, Tur\u00e1nyi E, Marosfoi M (2015) Evolution of flow-diverter endothelialization and thrombus organization in giant fusiform aneurysms after flow diversion: a histopathologic study. AJNR Am J Neuroradiol 36:1716\u20131720","journal-title":"AJNR Am J Neuroradiol"},{"key":"84_CR27","doi-asserted-by":"crossref","unstructured":"Dai D, Ding YH, Kelly M, Kadirvel R, Kallmes D (2016) Histopathological findings following pipeline embolization in a human cerebral aneurysm at the basilar tip. Interv Neuroradiol 22:153\u2013157","DOI":"10.1177\/1591019915622165"},{"key":"84_CR28","doi-asserted-by":"crossref","unstructured":"Grainger DJ, Wakefield L, Bethell HW, Farndale RW, Metcalfe JC (1995) Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Nat Med 1:932\u2013937","DOI":"10.1038\/nm0995-932"},{"key":"84_CR29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1146\/annurev.cb.03.110187.002303","volume":"3","author":"TF Deuel","year":"1987","unstructured":"Deuel TF (1987) Polypeptide growth factors: roles in normal and abnormal cell growth. Annu Rev Cell Biol 3:443\u2013492","journal-title":"Annu Rev Cell Biol"},{"key":"84_CR30","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1083\/jcb.102.4.1217","volume":"102","author":"RK Assoian","year":"1986","unstructured":"Assoian RK, Sporn MB (1986) Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol 102:1217\u20131223","journal-title":"J Cell Biol"},{"key":"84_CR31","doi-asserted-by":"crossref","unstructured":"Matsuda Y, Jang DK, Chung J, Wainwright JM, Lopes D (2018) Preliminary outcomes of single antiplatelet therapy for surface-modified flow diverters in an animal model: analysis of neointimal development and thrombus formation using OCT. J Neurointerv Surg 11:74\u201379","DOI":"10.1136\/neurintsurg-2018-013935"}],"container-title":["European Radiology Experimental"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-018-0084-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s41747-018-0084-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-018-0084-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T20:09:46Z","timestamp":1579637386000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurradiolexp.springeropen.com\/articles\/10.1186\/s41747-018-0084-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,22]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["84"],"URL":"https:\/\/doi.org\/10.1186\/s41747-018-0084-z","relation":{},"ISSN":["2509-9280"],"issn-type":[{"value":"2509-9280","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,22]]},"assertion":[{"value":"6 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. Institutional Animal Care and Use Committee approval was gained (Jacobs Institute, Buffalo, NY, USA). Consent to participate: not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RMM has a proctoring agreement with Phenox until 2017. PB has a consulting and proctoring agreement with Phenox. TL-H and CB are employees of Phenox. AS declares that he has no competing interests. PL is a consultant of Phenox. RH and HM are CEOs of Phenox. HH is a co-founder and shareholder of Phenox.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"3"}}